13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 37 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

ZEPP Stock Analysis & AI Quality Score

Data updated 2026-07-26

AI stock analysis and institutional research for Zepp Health Corp (ZEPP), a Technology sector company. ZEPP is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 37 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), Zepp Health Corp reports quarterly revenue of $258.9M, net income of $-40.1M, free cash flow of $-26.2M. Top institutional holders of ZEPP by reported 13-F value include MORGAN STANLEY, FIL Ltd, PRICE T ROWE ASSOCIATES, based on the most recent SEC filings. ZEPP trades on the NYSE exchange and files with the SEC under CIK 1720446. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ZEPP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Zepp Health Corp directly from SEC EDGAR.

Revenue

FY 2025

$258.9M

Net Income

FY 2025

$-40.1M

Free Cash Flow

FY 2025

$-26.2M

ROIC

FY 2025

-10.7%

D/E Ratio

FY 2025

0.28

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+41.8% YoY
$258.9MFY 2025
FY22 $4.14BFY23 $2.50BFY24 $182.6MFY25 $258.9M

Net Income

+47.1% YoY
$-40.1MFY 2025
FY22 $-43.2MFY23 $-31.0MFY24 $-75.7MFY25 $-40.1M

Operating Income

+38.1% YoY
$-29.2MFY 2025
FY22 $-61.9MFY23 $-30.4MFY24 $-47.3MFY25 $-29.2M

EPS (Diluted)

+44.8% YoY
$-0.16FY 2025
FY22 $-0.18FY23 $-0.13FY24 $-0.29FY25 $-0.16

Total Assets

+6.9% YoY
$564.8MFY 2025
FY22 $5.27BFY23 $635.5MFY24 $528.6MFY25 $564.8M

Total Debt

-21.0% YoY
$59.5MFY 2025
FY22 $684.2MFY23 $120.0MFY24 $75.2MFY25 $59.5M

Op. Cash Flow

-5.3% YoY
$-25.7MFY 2025
FY22 $-117.1MFY23 $42.6MFY24 $-24.4MFY25 $-25.7M

Free Cash Flow

-1.6% YoY
$-26.2MFY 2025
FY22 $-118.3MFY23 $41.0MFY24 $-25.8MFY25 $-26.2M

Get alerted when ZEPP's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Zepp Health Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put ZEPP on your watchlist

Track score changes the day Zepp Health Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is ZEPP a good stock to buy?

13F Pro's AI-powered analysis of Zepp Health Corp (ZEPP) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ZEPP are available on the ZEPP stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ZEPP is classified as a small company.

Which hedge funds own ZEPP?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ZEPP. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Zepp Health Corp's investment landscape.